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Open Access: should 
journals be free for all?
Steve Byford examines the issues and asks what would a change to
open access mean for science and the Society
Scholarly literature should be available freely online, with no accessrestrictions. There’s been an increasing amount of talk about this idea,
usually called Open Access, both in the general press and in the scientific
literature. Open Access journals would be funded instead by charges to
authors - or rather their funding bodies. The Society has been considering it
carefully for some time, and it continues to be a hot topic.
A recent related development is the Open Archive Initiative, which encourages
institutions to set up online repositories for their researchers’ papers, which would
then be available freely to all. This might not seem an immediate threat to
traditional journals, as no one wants to search across many institutions’ web sites.
However, new developments would allow readers to search across many such
repositories from special centralised search engines. Why should libraries pay for
journal subscriptions if their readers can easily access the same papers for free?
Open Access journals have been with us for some time, notably from
BioMedCentral, a commercial company, which has charged authors $500 (whilst
estimating that its costs are probably four times this). Lately the Public Library of
Science (PLoS), originally a pressure group, has become an Open Access publisher,
with PLoS Biology and PLoS Medicine already launched, and more titles promised.
PLoS charges $1500 per article but admits that this does not cover its costs.
There was recently a bill before the US House of Representatives (the ‘Sabo
bill’) that said ‘publicly funded research should be publicly available’. The
implication was that the funding for research would cover the costs of publication,
but this was not stated explicitly. Perhaps there was a naïve assumption that there
would be no costs. Several US newspapers picked up the story and ran articles
criticising publishers’ outrageous profits, the apparent implication being that all
scholarly publishers were equally guilty. Pressure from librarians is also continuing
- it is often attributed to the academics they serve, but we’ve rarely heard from
endocrinologists who are passionate about this!
More recently still, the UK House of Commons Select Committee on Science and
Technology (to which the Society made a submission) has produced a report
including, amongst its 82 conclusions, a recommendation that all UK-funded
research output be deposited on free online institutional repositories. In the US, the
NIH has produced draft proposals that would require all NIH-funded authors to
place their final, accepted manuscript on PubMed Central for free access, and for
journals publishing the papers to make them freely available no more than six
months after publication. The publisher Springer has announced an optional author-
pays, free-to-reader scheme (‘open choice’) for its journals. Elsevier now permits
authors to deposit their accepted papers on free-to-reader institutional repositories.
What should the Society’s view be?
What’s wrong with the current system?
It’s sometimes argued that the subscription model has served the academic
community well for decades, producing high-profile quality-assured journals. Why
throw that away? Wouldn’t it be better to defend it vigorously? The trouble is that
it has some deep flaws, leading some to wonder how long it can remain viable.
Perhaps the strongest symptom is the fact that most mature journals lose a
small percentage of their library subscribers every year. Since most of the costs of
publishing are independent of the number of copies produced, publishers’ unit
costs increase, which forces up journal prices. This leads to a vicious cycle of
further cancellations, since library budgets can’t keep up. The underlying cause is
not primarily irresponsible pricing by publishers (although not all have been
entirely innocent), but the mismatch between the funding for research on the one
hand, and the funding for the dissemination of its results on the other. Over the
last several decades, the amount of scientific research being done around the
world has grown enormously, resulting
in more and more research papers,
which needed to be published in more
or bigger journals. Libraries have not
usually been provided with anything
like the same proportion of extra
money with which to buy them. So
the round of cancellations began.
That’s not the only problem. The
journals market is dysfunctional in
other ways. For example, if you were
to sit down and compare the prices of
journals with their perceived quality, or
with their impact factor ranking, you
might be in for a shock. We have come
across journals from large commercial
publishers with prices up to five times
that of higher-impact, comparably
sized direct competitors from not-for-
profit learned societies. Why haven’t
market forces corrected this? It’s
perhaps largely because of the fact that
the decision to publish in a particular
journal is divorced from financial
factors - librarians know all about
prices, and researchers know all about
quality ranking. The two issues get
pondered in two separate sets of heads.
Are there other solutions?
Against a backdrop of restricted
purchasing power by libraries, how
might the Society seek to disseminate
its journals more widely, and still
protect its subscription revenue? It’s a
good question, because we’ve
historically relied on our journals to
be a major contributor to funding all
the other things we do for the benefit
of endocrinology, in fulfilment of our
charitable remit. This remains largely
the case, even though we’ve succeeded
in developing other revenue streams,
via BioScientifica’s growing range of
services.
One approach is to find ways of
giving a lot more online access (which
doesn’t cost much to provide) to
additional sites that wouldn’t have
been able to buy additional
conventional subscriptions, and to do
so for a comparatively small amount of
extra money. This is something that
appeals to consortia of universities, for
example, only some of whose
members currently have an
institutional subscription, or to large
companies who want online access to
their entire corporate network across
many sites. Clients get wider access,
we get wider dissemination and a little
more money - everyone wins!
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Well, almost. The trouble is, setting up and maintaining the terms of these
deals is a labour-intensive process. Librarians also find it easier to justify their time
if they can negotiate for a large number of journals at once, meaning that the large
commercial publishers end up with a considerable advantage, not least because
they find it easier to send out large, region-specific sales forces. Librarians often
end up committing large proportions of their budgets, often over several years, to
the very publishers they say over-price for lower-quality journals, whilst squeezing
the amount that’s left for the smaller publishers whose products they say offer
better value. It’s an odd world.
The Society has tried to combat this by co-operating with other small not-for-
profit publishers to offer its journals jointly with theirs. For example, we’ve
recently signed up to one initiative that offers 430 journals from 44 diverse
international small publishers. That should make us a bit more noticeable.
However, whilst ‘multi-site licencing’ stands a good chance of alleviating the
symptoms of the current problems, it doesn’t really address their root cause. It also
needs a lot of administrative effort.
How could Open Access help?
Immediate freedom of access to scholarly research results is intuitively attractive to
us all. As readers, we want ease of access from any location, as authors we want our
work to be disseminated as widely as possible. These expectations are frustrated by
a system that restricts access to just those journals our own library can afford.
The mismatch between funding for research and for its dissemination could be
removed at a stroke if research funding bodies included, as part of their research
grants, funds for authors to pay for the publication of their results.
The current mismatch between the price and quality of journals would be directly
under attack if an author’s choice of journal were influenced not only by the
journal’s perceived prestige and quality but also by the publication costs. Any
price differentials would then be transparent to the researcher and the market
would force a link between price and quality.
Under the new model, publishers would sell a service to authors. They would
be judged by the extent to which they maximised the exposure and credibility of
the work they published, and by how much added value they gave the work
compared with authors merely depositing their manuscripts on their institutions’
online repositories. 
The Society has been enthusiastic about the principle of an Open Access model
for some time. As far back as 1999 we were suggesting that the research grant,
rather than the library budget, would be a better funding route for research
dissemination, for precisely the reasons outlined above.
Why delay? Open Access today!
Well then, what’s to stop us embracing the new model? It’s perhaps obvious that it
won’t work for every kind of journal: what about clinical research for which there
is no grant? Similarly, it’s difficult to see how review journals could be financed
this way. Even so, what’s to stop us switching our basic science research journals
over to Open Access? How do we make the transition?
There’s the rub. A promising route
that captured the Society’s imagination
was the so-called ‘hybrid transition
model’. Charge the authors an optional
fee: if they choose to pay, their article
becomes free to all; if not, it’s
restricted to subscribers, as at present.
That looked as though it might take us
forward while limiting the risks.
Until you project the money we might
get. Our financial viability then turns out
to depend precariously on a few key
parameters. Firstly, how much should we
charge authors? Then, what proportion of
authors would take it up? Finally, how
would this affect our subscription
income? The answer to the first affects the
second, which in turn affects the third.
Set the price too low and we won’t get
enough money to cover our costs, and we
encourage a high level of take up. If that
means a substantial fraction of the journal
is free, many librarians will heave a sigh
of relief and cancel their subscription.
Under certain very plausible scenarios,
that could kill the journal that tries it. Set
the author fee at a more realistic level and
it will be perceived as extortionate, and
we lose the sympathy and loyalty of our
authors and readers.
It’s quite scary. Tweak these
parameters by not a lot, and the
Society could either be rolling in extra
cash or, quite simply, permanently out
of business. Worse still, because the
effects on subscriptions would not be
immediate, it could be two or three
years before a fatal decision took its
toll - we wouldn’t know until then
what its effect had been.
And that’s frustrating. We have here a
new model that could solve everything,
but which could destroy everything as
we edge towards it. It’s as though an
Open Access paradise is visible to us in
the distance, but in order to get there we
have to cross a bottomless ravine using
an unsafe rope bridge.
Unless we can find another way
over. Can we launch an Open Access
experiment without serious risk to our
financial viability? This is exercising our
minds greatly at the moment. Meanwhile,
your Council and Publications
Committee would be extremely
interested to hear your views! And
then, as they say, watch this space…
Comments, please, to Steve Byford 
at the Society’s office or via the website 
at www.endocrinology.org/sfe/forms/
contactform.htm.
